Elanco Animal Health Inc (5EA.DE)

Name: Elanco Animal Health Inc Financial Statements
Creator: Quarter Results

Healthcare | Medical Pharmaceuticals

Latest reporting period: 2025-12-31

Latest Quarter

2025-12-31

Revenue

$1.1B

Net Income

-$276M

Operating Margin

1.7%

Free Cash Flow

$284M

Debt / Assets

51.0%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for Elanco Animal Health Inc (5EA.DE).
Income Statement (Quarterly)	2025-12-31	2025-09-30	2025-06-30	2025-03-31
Revenue	1,144,000,000	1,137,000,000	1,241,000,000	1,193,000,000
Cost of Revenue	694,000,000	530,000,000	664,000,000	637,000,000
Gross Profit	450,000,000	607,000,000	577,000,000	556,000,000
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	338,000,000	351,000,000	400,000,000	341,000,000
Operating Expenses	431,000,000	580,000,000	492,000,000	435,000,000
Operating Income	19,000,000	27,000,000	85,000,000	121,000,000
Interest Expense	91,000,000	52,000,000	70,000,000	53,000,000
Income Before Tax	-259,000,000	-50,000,000	25,000,000	60,000,000
Income Tax Expense	17,000,000	-16,000,000	14,000,000	-7,000,000
Net Income	-276,000,000	-34,000,000	11,000,000	67,000,000
Per Share
EPS	-0.56	-0.07	0.02	0.14
EPS Diluted	0.00	0.00	0.00	0.00

Income statement annual history for Elanco Animal Health Inc (5EA.DE).
Income Statement (Annual)	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue	4,715,000,000	4,439,000,000	4,417,000,000	4,411,000,000	4,765,000,000
Cost of Revenue	2,665,000,000	2,530,000,000	1,931,000,000	1,913,000,000	2,134,000,000
Gross Profit	2,050,000,000	1,909,000,000	2,486,000,000	2,498,000,000	2,631,000,000
Operating Expenses
R&D Expenses	0	0	0	0	0
SG&A Expenses	1,430,000,000	1,314,000,000	1,280,000,000	1,259,000,000	1,404,000,000
Operating Expenses	1,798,000,000	1,658,000,000	1,613,000,000	2,329,000,000	2,329,000,000
Operating Income	252,000,000	251,000,000	873,000,000	390,000,000	302,000,000
Interest Expense	220,000,000	339,000,000	0	241,000,000	236,000,000
Income Before Tax	-224,000,000	488,000,000	-1,195,000,000	-72,000,000	-567,000,000
Income Tax Expense	8,000,000	150,000,000	36,000,000	6,000,000	-95,000,000
Net Income	-232,000,000	338,000,000	-1,231,000,000	-78,000,000	-472,000,000
Per Share
EPS	-0.47	0.68	-2.50	-0.16	-0.97
EPS Diluted	0.00	0.00	0.00	0.00	0.00

Balance sheet quarterly history for Elanco Animal Health Inc (5EA.DE).
Balance Sheet (Quarterly)	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Assets
Cash and Cash Equivalents	545,000,000	468,000,000	352,000,000	345,000,000
Short Term Investments	0	0	0	14,000,000
Net Receivables	940,000,000	886,000,000	842,000,000	0
Inventory	1,737,000,000	1,574,000,000	1,735,000,000	1,538,000,000
Total Current Assets	3,458,000,000	3,215,000,000	3,407,000,000	3,279,000,000
Property Plant Equipment	1,409,000,000	993,000,000	1,166,000,000	1,140,000,000
Goodwill and Intangibles	8,187,000,000	8,095,000,000	9,588,000,000	10,835,000,000
Total Assets	13,358,000,000	12,614,000,000	14,362,000,000	15,491,000,000
Liabilities
Account Payables	368,000,000	296,000,000	270,000,000	390,000,000
Short Term Debt	74,000,000	44,000,000	70,000,000	0
Total Current Liabilities	1,597,000,000	1,315,000,000	1,241,000,000	1,702,000,000
Long Term Debt	3,943,000,000	4,277,000,000	5,846,000,000	5,448,000,000
Total Liabilities	6,811,000,000	6,518,000,000	8,139,000,000	8,202,000,000
Shareholders Equity
Retained Earnings	-2,182,000,000	-1,950,000,000	-2,288,000,000	-1,057,000,000
Total Shareholders Equity	6,547,000,000	6,096,000,000	6,223,000,000	-1,057,000,000

Balance sheet annual history for Elanco Animal Health Inc (5EA.DE).
Balance Sheet (Annual)	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Assets
Cash and Cash Equivalents	545,000,000	468,000,000	352,000,000	345,000,000	638,000,000
Short Term Investments	0	0	0	14,000,000	0
Net Receivables	940,000,000	886,000,000	842,000,000	0	1,028,000,000
Inventory	1,737,000,000	1,574,000,000	1,735,000,000	1,538,000,000	1,373,000,000
Total Current Assets	3,458,000,000	3,215,000,000	3,407,000,000	3,279,000,000	3,276,000,000
Property Plant Equipment	1,409,000,000	993,000,000	1,166,000,000	1,140,000,000	1,061,000,000
Goodwill and Intangibles	8,187,000,000	8,095,000,000	9,588,000,000	10,835,000,000	11,759,000,000
Total Assets	13,358,000,000	12,614,000,000	14,362,000,000	15,491,000,000	16,483,000,000
Liabilities
Account Payables	368,000,000	296,000,000	270,000,000	390,000,000	418,000,000
Short Term Debt	74,000,000	44,000,000	70,000,000	0	294,000,000
Total Current Liabilities	1,597,000,000	1,315,000,000	1,241,000,000	1,702,000,000	1,643,000,000
Long Term Debt	3,943,000,000	4,277,000,000	5,846,000,000	5,448,000,000	6,025,000,000
Total Liabilities	6,811,000,000	6,518,000,000	8,139,000,000	8,202,000,000	8,945,000,000
Shareholders Equity
Retained Earnings	-2,182,000,000	-1,950,000,000	-2,288,000,000	-1,057,000,000	-949,000,000
Total Shareholders Equity	6,547,000,000	6,096,000,000	6,223,000,000	-1,057,000,000	7,538,000,000

Cash flow quarterly history for Elanco Animal Health Inc (5EA.DE).
Cash Flow Statement (Quarterly)	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Operating Activities
Net Income	-232,000,000	338,000,000	-1,231,000,000	-78,000,000
Depreciation & Amortization	680,000,000	662,000,000	694,000,000	617,000,000
Stock Based Compensation	68,000,000	55,000,000	46,000,000	59,000,000
Change in Working Capital	99,000,000	149,000,000	-206,000,000	-255,000,000
Operating Cash Flow	560,000,000	541,000,000	271,000,000	452,000,000
Investing Activities
Capital Expenditure	-276,000,000	-147,000,000	-140,000,000	-137,000,000
Investments	-276,000,000	-147,000,000	-140,000,000	-137,000,000
Investing Cash Flow	-279,000,000	1,158,000,000	-169,000,000	-179,000,000
Financing Activities
Debt Repayment	-563,000,000	-1,475,000,000	-77,000,000	0
Common Stock Issued/Repurchased	0	0	0	0
Dividends Paid	0	0	0	0
Financing Cash Flow	-275,000,000	-1,492,000,000	-83,000,000	-549,000,000
Summary
Free Cash Flow	284,000,000	394,000,000	131,000,000	315,000,000
Net Change in Cash	77,000,000	116,000,000	7,000,000	-293,000,000

Cash flow annual history for Elanco Animal Health Inc (5EA.DE).
Cash Flow Statement (Annual)	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Operating Activities
Net Income	-232,000,000	338,000,000	-1,231,000,000	-78,000,000	-472,000,000
Depreciation & Amortization	680,000,000	662,000,000	694,000,000	617,000,000	716,000,000
Stock Based Compensation	68,000,000	55,000,000	46,000,000	59,000,000	66,000,000
Change in Working Capital	99,000,000	149,000,000	-206,000,000	-255,000,000	-87,000,000
Operating Cash Flow	560,000,000	541,000,000	271,000,000	452,000,000	483,000,000
Investing Activities
Capital Expenditure	-276,000,000	-147,000,000	-140,000,000	-137,000,000	-197,000,000
Investments	-276,000,000	-147,000,000	-140,000,000	-137,000,000	-126,000,000
Investing Cash Flow	-279,000,000	1,158,000,000	-169,000,000	-179,000,000	-530,000,000
Financing Activities
Debt Repayment	-563,000,000	-1,475,000,000	-77,000,000	0	-823,000,000
Common Stock Issued/Repurchased	0	0	0	0	0
Dividends Paid	0	0	0	0	0
Financing Cash Flow	-275,000,000	-1,492,000,000	-83,000,000	-549,000,000	210,000,000
Summary
Free Cash Flow	284,000,000	394,000,000	131,000,000	315,000,000	286,000,000
Net Change in Cash	77,000,000	116,000,000	7,000,000	-293,000,000	132,000,000